Your browser doesn't support javascript.
loading
The effects of somatostatin analogues on glycaemia in the treatment of neuroendocrine tumours.
Patel, Kishen Rajan; Nahar, Ananda; Elhassan, Yasir S; Shetty, Shishir; Smith, Stacey; Vickrage, Suzanne; Kemp-Blake, Joanne; Palani, Raghavendar; Geh, Ian; Venkataraman, Hema; Shah, Tahir; Ayuk, John.
Afiliação
  • Patel KR; Birmingham Neuroendocrine Tumour Centre, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
  • Nahar A; Oncology Department, St Bartholomew's Hospital, Bart's Health NHS Foundation Trust, London, UK.
  • Elhassan YS; Birmingham Neuroendocrine Tumour Centre, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
  • Shetty S; Birmingham Neuroendocrine Tumour Centre, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
  • Smith S; Birmingham Neuroendocrine Tumour Centre, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
  • Vickrage S; Birmingham Neuroendocrine Tumour Centre, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
  • Kemp-Blake J; Birmingham Neuroendocrine Tumour Centre, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
  • Palani R; Birmingham Neuroendocrine Tumour Centre, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
  • Geh I; Birmingham Neuroendocrine Tumour Centre, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
  • Venkataraman H; Birmingham Neuroendocrine Tumour Centre, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
  • Shah T; Birmingham Neuroendocrine Tumour Centre, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
  • Ayuk J; Birmingham Neuroendocrine Tumour Centre, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
J Neuroendocrinol ; 34(4): e13064, 2022 04.
Article em En | MEDLINE | ID: mdl-35078270
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tumores Neuroendócrinos / Diabetes Mellitus Tipo 2 Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: J Neuroendocrinol Assunto da revista: ENDOCRINOLOGIA / NEUROLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tumores Neuroendócrinos / Diabetes Mellitus Tipo 2 Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: J Neuroendocrinol Assunto da revista: ENDOCRINOLOGIA / NEUROLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido